Selective variegated methylation of the p15 CpG island in acute myeloid leukemia

International Journal of Cancer

Volumn 78, Issue 5, 1998, Pages 561-567

  Dodge, Jonathan E ^a   List, Alan F ^b   Futscher, Bernard W ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; DNA METHYLATION; DNA SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LEUKEMOGENESIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CPG ISLANDS; DEOXYCYTIDINE KINASE; DNA METHYLATION; FEMALE; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MOLECULAR SEQUENCE DATA;

EID: 0031735065     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981123)78:5<561::AID-IJC6>3.0.CO;2-R     Document Type: Article

References (22)

1. ANTEQUERA, F. and BIRD A., Number of CpG islands and genes in human and mouse. Proc. nat. Acad. Sci. (Wash.), 90, 11995-11999 (1993).
2. BHALLA, K., NAYAK, R. and GRANT, S., Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-β-D-arabinofuranosylcytosine. Cancer Res., 44, 5029- 5037 (1984).
3. BIRD, A., The essentials of DNA methylation. Cell 70, 5-8 (1992).
4. CHEN, E.H., JOHNSON II, E.E., VETTER, S.M. and MITCHELL, B.S., Character ization of the deoxycytidine kinase promoter in human lymphoblast cell lines. J. clin. Invest., 95, 1660-1668 (1995).
5. CHOTTINER, E.G., SHEWACH, D.S., DATTA, N.S., ASHCRAFT, E., GRIBBIN, D., GINSBURG, D., FOX, I.H. and MITCHELL, B.S., Cloning and expression of human deoxycytidine kinase cDNA. Proc. nat. Acad. Sci. (Wash.), 88, 1531-1535 (1991).
6. CLARK, S.J., HARRISON, J., PAUL, C.L. and FROMMER, M., High sensitivity mapping of methylated cytosines. Nucleic Acids Res., 22, 2990-2997 (1994).
7. FEARON, E.R. and VOGELSTEIN, B., A genetic model for colorectal tumorigenesis. Cell, 61, 759-767 (1990).
8. FLASSHOVE, M., STRUMBERG, D., AYSCUE, L., MITCHELL, B.S., TIRIER, C., HEIT, W., SEEBER, S. and SCHUTTE, J., Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside. Leukemia, 8, 780-785 (1994).
9. GARDINER-GARDEN, M. and FROMMER, M., CpG islands in vertebrate genomes. J. mol. Biol., 196, 261-282 (1987).
10. GONZALEZ-ZULUETA, M., BENDER, C.M., YANG, A.S., NGUYEN, T., BEART, R.W., VAN TURNOUT, J.M. and JONES, P.A., Methylation of the 5′ CpG island of the P16/CDKN2 tumor suppressor gene in normal and transformed human tissue correlates with gene silencing. Cancer Res., 55, 4531-4535 (1995).
11. GRANT, S., TURNER, A., NELMS, P. and YANOVICH, S., Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1-β-D-arabinofuranosylcytosine, Leukemia, 9, 808-814 (1995).
12. INK4A characterize the major types of hematological malignancies. Cancer Res., 57, 837-841 (1997).
13. INK4B1. Cancer Res., 56, 722-727 (1996).
14. HERMAN, J.G., MERLO, A., MAO, L., LAPIDUS, R.G., ISSA, J.-P.J., DAVIDSON, N.E., SIDRANSKY, D. and BAYLIN, S.B., Inactivation of the CDKN2/p16/ MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530 (1995).
15. JEN, J., HARPER, W., BIGNER, S.H., BIGNER, D.D., PAPADOPOULOS, N., MARKOWITZ, S., WILLISON, J.K.V., KINZLER, K.W. and VOGELSTEIN, B., Deletion of p16 and p15 genes in brain tumors. Cancer Res., 54, 6353-6358 (1994).
16. MERLO, A., HERMAN, J.G., MAO, L., LEE, D.J., GABRIELSON, E., BURGER, P.C., BURGER, P.C., BAYLIN, S.B. and SIDRANSKY, D., 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature (Med.), 1, 686- 692 (1995).
17. OWENS, J.K., SHEWACH, D.S., ULLMAN, B. and MITCHELL, B.S., Resistance to 1-β-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene. Cancer Res., 52, 2389- 2393 (1992).
18. SERRANO, M., HANNON, G.J. and BEACH, D., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366, 704-707 (1993).
19. SONG, J.J., WALKER, S., CHEN, E., JOHNSON II, E.E., SPYCHALA, J., GRIBBIN, T. and MITCHELL, B.S., Genomic structure and chromosomal localization of the human deoxycytidine kinase gene. Proc. nat. Acad. Sci. (Wash.), 90, 431-434 (1993).
20. STIRZAKER, C., MILLAR, D.S., PAUL, C.L., WARNECKE, P.M., HARRISON, J., VINCENT, P.C., FROMMER, M. and CLARK, S.J., Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res., 57, 2229-2237 (1997).
21. 6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol. cell. Biol., 17, 5612-5619 (1997).
22. YOSHIURA, K., KANAI, Y., OCHIAI, A., SHIMOYAMA, Y., SUGIMURA, T. and HIROHASI, S., Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. nat. Acad. Sci. (Wash.), 92, 7416-7419 (1995).